The Octopus Value Investing

Novo Nordisk - FY 2025 Earnings Review

Adjusted 2026 Guidance Killed the Relief Rally (15 min read)

The Octopus Value Investing

MiscellaneousMiscellaneous

Dec 07, 2025

#5 Investment Sidebar Snapshots

Reviewing New Data of Novo Nordisk Business, Schott Pharma Preliminary FY25 Results & a New Investment Thesis

The Octopus Value Investing

PandoraPandora

Nov 30, 2025

Pandora Valuation Update

Is Pandora's Stock Price Reflecting its Intrisinc Value?

The Octopus Value Investing

PandoraPandora

+1+1

Nov 18, 2025

Pandora A/S - Q3 2025 Earnings Review

The Market Turns Overly Pessimistic on External Headwinds Not Only Affecting Pandora

The Octopus Value Investing

Earnings ReviewEarnings Review

+1+1

Nov 09, 2025

Novo Nordisk - Q3 2025 Earnings Review

Disappointing, Yes. Unexpected, No.

The Octopus Value Investing

MiscellaneousMiscellaneous

Sep 28, 2025

#4 Investment Sidebar Snapshots

September 2025 News & Insights Recap

The Octopus Value Investing

Theon InternationalTheon International

Sep 14, 2025

Theon International - Quantitative Analysis

Financials just made my conviction grow bigger

The Octopus Value Investing

MiscellaneousMiscellaneous

Aug 24, 2025

#3 Investment Sidebar Snapshots

Monlunabant, Novo Nordisk & Lesson from 10 Years of US Biosimilars Market

The Octopus Value Investing

PandoraPandora

+1+1

Aug 18, 2025

Pandora A/S - H1 2025 Earnings Review

The Stocks Plunging While the Company is Meeting the FY25 Guidance

The Octopus Value Investing

Novo NordiskNovo Nordisk

Aug 10, 2025

Novo Nordisk - H1 2025 Earnings Review

Lars Fruergaard's Final Earnings as CEO

The Octopus Value Investing

PandoraPandora

Jul 27, 2025

Alexander Lacik, CEO of Pandora, Interview in "Ett Rikare Liv" Podcast

Highlights and Transcripts Translated to English

The Octopus Value Investing

The Octopus PortfolioThe Octopus Portfolio

Jul 20, 2025

#4 The Journey of Compounding - H1 2025 Letter to Readers

Reflections of a Hectic Semester in the Market

The Octopus Value Investing

First Back

1 2 3 4 5 6 7

Next Last

Archive

Novo Nordisk - FY 2025 Earnings Review

#5 Investment Sidebar Snapshots

Pandora Valuation Update

Pandora A/S - Q3 2025 Earnings Review

Novo Nordisk - Q3 2025 Earnings Review

#4 Investment Sidebar Snapshots

Theon International - Quantitative Analysis

#3 Investment Sidebar Snapshots

Pandora A/S - H1 2025 Earnings Review

Novo Nordisk - H1 2025 Earnings Review

Alexander Lacik, CEO of Pandora, Interview in "Ett Rikare Liv" Podcast

#4 The Journey of Compounding - H1 2025 Letter to Readers